Browse result page of THPdb

The total number entries retrieved from this search are 58

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1148	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAdvate	CompanyN.A.	Physical AppearancePowder form	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1149	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAlphanate	CompanyN.A.	Physical AppearanceLyophilized powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1150	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandBioclate	CompanyBaxter Healthcare Corporation, Hyland Division and Genetics Institute, Inc.	Physical AppearanceSterile, nonpyrogenic, off-white to faint yellow, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1151	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHelixate FS	CompanyN.A.	Physical AppearanceSterile, stable, purified, nonpyrogenic, dried concentrate	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1152	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHemofil M	CompanyN.A.	Physical AppearanceDry concentrate	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1153	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHyate:C	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1154	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandKoate-HP	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1155	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandKogenate FS	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1156	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandMonarc-M	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1157	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandMonoclate-P	CompanyN.A.	Physical AppearanceLyophilized powder for solution	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1158	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandReFacto	CompanyN.A.	Physical AppearanceLyophilized powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1159	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandXyntha	CompanyN.A.	Physical AppearanceSterile, nonpyrogenic, preservative-free, freeze-dried powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1205	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandHumulin R	CompanyEli Lilly and Company	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision.	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1206	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandNovolin R	CompanyNovo Nordisk	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1210	ThPPIDTh1028	NameTenecteplase	Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view	Length255	Functional ClassificationIb	DiseaseHematological,Metabolic	BrandTNKase	CompanyGenentech Inc	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionIntravenous Injection	CategoryThrombolytic Agents, Fibrinolytic agents	TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1,Plasminogen activator inhibitor 2,Tetranectin,Keratin, type II cytoskeletal 8,Annexin A2,Calreticulin,Calnexin,Prolow-density lipoprotein
ID1246	ThPPIDTh1034	NamePalifermin	Peptide SequenceSYDYMEGGDIRVRRLFCRTQ Full view	Length140	Functional ClassificationIb	DiseaseCancer	BrandKepivance	CompanyAmgen Inc	Physical AppearanceSterile, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryAnti-Mucositis Agents	TargetFibroblast growth factor receptor 2,Neuropilin-1,Fibroblast growth factor receptor 1,Fibroblast growth factor receptor 4,Fibroblast growth factor receptor 3,Basement membrane-specific heparan sulfate proteoglycan core protein
ID1260	ThPPIDTh1037	NameBotulinum Toxin Type B	Peptide SequenceMPVTINNFNYNDPIDNNNII Full view	Length255	Functional ClassificationIc	DiseaseNeurological Disorder	BrandMyobloc	CompanySolstice Neurosciences	Physical AppearanceClear and colorless to light-yellow sterile injectable solution	Route of AdministartionInjection	CategoryAntidystonic Agents	TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
ID1261	ThPPIDTh1037	NameBotulinum Toxin Type B	Peptide SequenceMPVTINNFNYNDPIDNNNII Full view	Length255	Functional ClassificationIc	DiseaseNeurological Disorder	BrandNeurobloc	CompanySolstice Neurosciences	Physical AppearanceClear and colourless to light yellow solution	Route of AdministartionIntramuscular Injection	CategoryAntidystonic Agents	TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2
ID1358	ThPPIDTh1050	NamePegademase bovine	Peptide SequenceMAQTPAFNKPKVELHVHLDG Full view	Length255	Functional ClassificationIa	DiseaseMetabolic	BrandAdagen	CompanyEnzon Inc.	Physical AppearanceIsotonic, pyrogen free, sterile solution, pH 7.2-7.4	Route of AdministartionIntramusular Injection	CategoryEnzyme Replacement Agents	TargetAdenosine,Growth factor receptor-bound protein 2
ID1365	ThPPIDTh1053	NameSerum albumin iodonated	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length600	Functional ClassificationIV	DiseaseHematological Disorders	BrandMegatope	CompanyIsoTex Diagnostics	Physical AppearanceColorless to very pale yellow solutions	Route of AdministartionInjection for Intravenous administration	CategoryDiagnostic Agents	TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP
ID1366	ThPPIDTh1053	NameSerum albumin iodonated	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length600	Functional ClassificationIV	DiseaseHematological Disorders	BrandJeanotope	CompanyIsoTex Diagnostics	Physical AppearanceSterile, nonpyrogenic, aqueos solution	Route of AdministartionIntravenous infusion	CategoryDiagnostic Agents	TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP
ID1367	ThPPIDTh1053	NameSerum albumin iodonated	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length600	Functional ClassificationIV	DiseaseHematological Disorders	BrandVolumex	CompanyIsoTex Diagnostics	Physical AppearanceColorless to very pale yellow.	Route of AdministartionIntravenous infusion	CategoryDiagnostic Agents	TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP
ID1385	ThPPIDTh1061	NameTrastuzumab	Peptide SequenceLight chain 1: DIQMT Full view	Length1364	Functional ClassificationIIa	DiseaseCancer	BrandHerceptin	CompanyGenentech	Physical AppearanceSterile, white to pale yellow, preservative-free lyophilized powder	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1403	ThPPIDTh1065	NameDigoxin Immune Fab (Ovine)	Peptide SequenceHeavy Chain: EVQLQQS Full view	Length438	Functional ClassificationIIa	DiseaseCardiac	BrandDIGIBIND	CompanyGalaxo Smith Kline	Physical AppearanceSterile lyophilized powder of antigen binding fragments (Fab) derived from specific antidigoxin antibodies raised in sheep.	Route of AdministartionIntravenous infusion after reconstitution with Sterile Water for Injection	CategoryAntidotes	TargetT-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface glycoprotein CD3 gamma chain, T-cell surface glycoprotein CD3 zeta chain, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1404	ThPPIDTh1065	NameDigoxin Immune Fab (Ovine)	Peptide SequenceHeavy Chain: EVQLQQS Full view	Length438	Functional ClassificationIIa	DiseaseCardiac	BrandDigiFab	Company Protherics Inc	Physical AppearanceSterile, purified, lyophilized preparation of digoxin-immune ovine Fab (monovalent) immunoglobulin fragments.ÂÂÂ	Route of AdministartionIntravenous administrationÂÂÂ	CategoryAntidotes	TargetT-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface glycoprotein CD3 gamma chain, T-cell surface glycoprotein CD3 zeta chain, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1422	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPancrecarb	CompanyDigestive care US, Inc.	Physical AppearanceDelayed-Release Capsules, Buffered and Enteric-Coated Microspheres.	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1423	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandViokace	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble in alcohol and converted to tablet form	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1424	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRESA	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether and converted to Delayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1425	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPERTZYE	CompanyDigestive care US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether PERTZYE delayed-release capsule	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1426	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRASE	CompanyAxcan Pharma	Physical AppearanceCapsules Enteric-Coated Microspheres	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1427	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandZENPEP	CompanyAptalis Pharma US, Inc.	Physical AppearanceDelayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1434	ThPPIDTh1074	NameAlglucerase	Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view	Length497	Functional ClassificationIa	DiseaseMetabolic	BrandCeredase	CompanyGenzyme Corporation	Physical AppearanceClear sterile non-pyrogenic solution of alglucerase in a citrate buffered solution	Route of AdministartionIntravenous injection	CategoryEnzyme Replacement Agents	TargetPlasminogen,Proteinase-activated receptor 1
ID1454	ThPPIDTh1084	NameBecaplermin	Peptide SequenceSLGSLTIAEPAMIAECKTRT Full view	Length109	Functional ClassificationIb	DiseaseCardiac	BrandREGRANEX	CompanyOMJ Pharmaceuticals, Inc. San German, Puerto Rico	Physical AppearanceGel: 0.01 %; clear, colorless to straw-colored gel	Route of AdministartionExternal use only	CategoryAngiogenesis Inducing Agents	TargetT-cell surface glycoprotein CD1a,Major histocompatibility complex class I-related gene protein,Integrin alpha-L,T-lymphocyte activation antigen CD86,Low affinity immunoglobulin gamma Fc region receptor II-b,T-cell surface glycoprotein CD4,Integrin beta-1,Integrin alpha-V,Integrin beta-3
ID1456	ThPPIDTh1086	NameInterferon Alfa-2B, Recombinant	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandINTRON® A	CompanyMerck	Physical AppearancePowder or solution	Route of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injection	CategoryImmunosuppressive Agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
ID1462	ThPPIDTh1088	NameEnfuvirtide	Peptide SequenceYTSLIHSLIEESQNQQEKNE Full view	Length36	Functional ClassificationIIa	DiseaseInfectious	Brand`FUZEON	CompanyTrimeris, Roche	Physical AppearanceWhite to off-white, sterile, lyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryHIV Fusion Inhibitors	TargetOxytocin receptor,Oxytocin-neurophysin 1, Envelope glycoprotein
ID1466	ThPPIDTh1090	NameDaclizumab	Peptide SequenceQVQLVQSGAEVKKPGSSVKV Full view	Length674	Functional ClassificationIIa	DiseaseImmunologicals	BrandZenapax	CompanyRoche	Physical AppearanceClear, sterile, colorless concentrate for further dilution and intravenous administration	Route of AdministartionIntravenous injection	CategoryImmunosuppressive Agents	TargetFusion glycoprotein F0,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1480	ThPPIDTh1099	NameMecasermin	Peptide SequenceGPETLCGAELVDALQFVCGD Full view	Length70	Functional ClassificationIb	DiseaseHormonal	BrandN.A.	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryN.A.	TargetInsulin-like growth factor 1 receptor,Insulin-like growth factor-binding protein 3,Insulin receptor,Cation-independent mannose-6-phosphate receptor
ID1482	ThPPIDTh1100	NamePramlintide	Peptide SequenceKCNTATCATQRLANFLVHSS Full view	Length37	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandSymlin	CompanyAmylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)	Physical AppearanceClear, isotonic, sterile solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetCalcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3
ID1548	ThPPIDTh1117	NameIpilimumab	Peptide SequenceHeavy chain: QVQLVES Full view	Length663	Functional ClassificationIIIc	DiseaseCancer	BrandYERVOY	CompanyBristol-Myers Squibb	Physical AppearanceSterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution	Route of AdministartionN.A.	CategoryAntineoplastic Agents and Monoclonal antibodies	TargetCytotoxic T-lymphocyte protein 4
ID1560	ThPPIDTh1121	NamePertuzumab	Peptide Sequencelight chain DIQMTQSP Full view	Length664	Functional ClassificationIIIc	DiseaseCancer	BrandPerjeta	CompanyGenentech	Physical AppearanceSterile, clear to slightly opalescent, colorless to pale brown liquid	Route of AdministartionIntravenous infusion	CategoryMonoclonal antibodies	TargetReceptor tyrosine-protein kinase erbB-2
ID1562	ThPPIDTh1122	NameRilonacept	Peptide Sequencerilonacept|Homo sapi Full view	Length880	Functional ClassificationIIa	DiseaseImmunological	BrandArcalyst	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterleukin-1 beta,Interleukin-1 alpha,Interleukin-1 receptor antagonist protein
ID1659	ThPPIDTh1152	NameDrotrecogin alfa	Peptide SequenceHeavy Chain: LIDGKMT Full view	Length402	Functional ClassificationIb	DiseaseInfectious	BrandXigris	CompanyEli Lilly and Company	Physical AppearanceSterile, lyophilized, white to off-white powder	Route of AdministartionIntravenous Infusion	CategoryAntisepsis	TargetCoagulation factor VIII, V, Plasminogen activator inhibitor 1, Thrombomodulin, Vitamin K-dependent protein S, Ceruloplasmin, Prothrombin, Platelet factor 4, Plasma serine protease inhibitor, Serpin B6, Vitamin K-dependent gamma-carboxylase, Endothelial protein C receptor
ID1663	ThPPIDTh1155	NameUrokinase	Peptide SequenceKPSSPPEELKFQCGQKTLRP Full view	Length276	Functional ClassificationIb	DiseaseHaemetological	BrandKinlytic	CompanyN.A.	Physical AppearanceSterile lyophilized white powder	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetPlasminogen,Urokinase plasminogen activator surface receptor, Urokinase-type plasminogen activator, Tissue-type plasminogen activator, Plasminogen activator inhibitor 1, 2, Plasma serine protease inhibitor, Low-density lipoprotein receptor-related protein 2, Suppressor of tumorigenicity 14 protein, Nidogen-1
ID1673	ThPPIDTh1160	NameSatumomab Pendetide	Peptide SequenceHeavy Chain 1: QVQLQ Full view	Length1299	Functional ClassificationIV	DiseaseDiagnostic Agents	BrandOncoScint	CompanyCytogen Corp, Lonza Biologics	Physical AppearanceN.A.	Route of AdministartionIntravenous Injection	CategoryDiagnostic Agents	TargetTumor-associated glycoprotein 72 (TAG-72)
ID1678	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis U.S. Llc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 9
ID1679	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 10
ID1680	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis Canada Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 11
ID1681	ThPPIDTh1162	NameAlirocumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIc	DiseaseMetabolic/Cardiac	BrandPraluent	CompanySanofi Aventis U.S. Llc	Physical AppearanceInjection, Solution	Route of AdministartionSubcutaneous	CategoryN.A.	TargetProprotein convertase subtilisin/kexin type 14
ID1708	ThPPIDTh1170	NameBlinatumomab	Peptide SequenceDIQLTQSPASLAVSLGQRAT Full view	Length504	Functional ClassificationIIIc	DiseaseCancer/Genetic	BrandBlincyto	CompanyAMGEN	Physical AppearanceLyophilized Powder for intravenous administration	Route of AdministartionIntravenous	CategoryAntineoplastic Agents, Immunosuppressive Agents, Monoclonal antibodies, Antineoplastic and Immunomodulating Agents	TargetB-lymphocyte antigen CD19; T-cell surface glycoprotein CD3 delta chain